A significant reduction in clinically relevant nonmajor bleeding was observed with tinzaparin ( @ of @ patients for tinzaparin vs @ of @ patients for warfarin ; HR , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) .